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Introduction: Intensive research over the last six decades has resulted in minimal 
improvement in vascular graft development.  Small animal models are the first line of species 
exposed to vascular graft implantation and invasive monitoring of experimental graft patency 
may contribute to pain, suffering, higher cost and earlier sacrifice.  Non-invasive 
ultrasonographic evaluation of vascular implants during the conduction of animal studies 
allows for chronic follow-up with multiple assessments.  This study aims to apply and endorse 
the utilization of ultrasound as a less invasive diagnostic method in determining patency of 
vascular grafts in units where imaging modalities like Computerized Tomography (CT) and 
Magnetic Resonance Imaging (MRI) are not readily available. 
 
Methods: Pre-operative control ultrasound evaluation of the ejection fraction, aortic diameter 
and aortic velocity were conducted on Wistar rats (250-350g).  Infra-renal aortic vascular graft 
implantation was then performed, with 8 rats receiving straight (1.8mm ID, 18mm length) 
expanded polytetrafluoroethylene (ePTFE) grafts, while 12 rats received a long (1.8mm ID, 
100mm length) looped ePTFE conduit with a sealed mid-graft (10mm length) section.  
Ultrasonography was conducted on days 1, 3, 7 and weeks 4, 8 and 12 post operatively.  
Grafts were explanted if there was any ultrasonographic evidence of occlusion or at twelve- 
week termination of the study.  Explant was preceded by angiography and followed by 
histological assessment of the grafts for patency.  
 
Results:  Three of the looped and all 8 of the straight grafts were patent at the 12 week explant 
time point, as correctly assessed by ultrasound and confirmed by angiography and histology. 
Three of the nine occluded looped grafts were explanted at eight weeks due to early 
ultrasonographic detection of occlusion; the remaining 6 were explanted at twelve weeks. 
There were two false positive results, which were incorrectly assessed as patent at twelve 
weeks of implantation on ultrasonographic evaluation, but confirmed to be occluded on 
angiography at explant.  The results of ultrasonography evaluation of implanted infra-renal 
vascular grafts had a high specificity of 100% with a sensitivity of 78%.  The outcome of the 
results between ultrasound and angiography corresponded in 18 out of 20 vascular grafts, 
with a calculated positive predictive value (PPV) of 100% and a negative predictive value 




Conclusion: Ultrasound is easily available and a non-invasive diagnostic modality allowing 
for safe and reliable results, which may be repeated at different time frames following vascular 
implants in small animal models.  Ultrasonographic limitations exist, emphasizing the need for 
an experienced operator with adequate knowledge and training.  Its use may be complicated 
by tortuous geometries of vessels, which is technically more challenging to evaluate with 
ultrasound than with imaging techniques like CT and MRI.  It does, however, add information 
without additional loss of life or increased use of animal numbers.  Ultrasound is an essential 
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Ultrasound is a non-invasive diagnostic tool which has seen great advances since its 
development in the mid twentieth century.(1, 2)  Ultrasound imaging was first used in animals 
in the 1980s, when grey-scale ultrasonic imaging could view the reproductive organs and 
cycles in horses and cattle.(3, 4)  The improvements in ultrasound technology have led to the 
progression from large bulky machines with suboptimal imaging, to portable, sophisticated, 
diagnostic instruments which combine elements of physics, engineering, physiology and 
medicine into a single functional imaging modality.(1) Due to the non-invasive nature of 
ultrasonography as an imaging technique and its ease of use, it is now widely used in a great 
diversity of modalities and applications and has expanded and revolutionized research in 
animals. (3, 5) 
Small animal models are considered to be the low cost and high throughput model of choice 
in the initial in vivo analysis of vascular grafts.(2, 6)  Pre-clinical research aims to develop 
vascular graft materials that mimic the structure and function of autologous vessels.(7)  These 
grafts may be of use in human recipients who do not have sufficient autologous conduits to 
treat coronary artery disease, peripheral vascular disease or to provide vascular access for 
renal dialysis.(7, 8)  Invasive methods may be used to determine patency of experimental 
vascular grafts in animals, but this has significant consequences.(6, 9, 10)  Invasive monitoring 
in animal research may contribute to pain, suffering, higher cost and earlier sacrifice of animals 
due to humane end points being reached.(6, 10)  Non-invasive ultrasonographic imaging to 
determine patency of vascular graft implants in animal studies, allows for long term follow-up 
where multiple evaluations may be needed.(10, 11)  Limited research has been published on 
use and efficacy of various modes of ultrasound in the evaluation of vascular graft patency in 
rodent models.(8, 12-17)  Vascular graft development is an ongoing field of research and these 
novel techniques of neoartery formation with biodegradable tissues and in vitro studies, take 
time and prolonged experimental implantation in animal models.(7)  Therefore 
ultrasonography may be used as a less invasive diagnostic imaging modality, to assess 




2. Clinical Vascular Conduits  
 
Cardiovascular pathology is one of the leading causes of mortality and accounts for 30% of 
deaths world-wide, of which coronary artery disease (CAD) caused by atherosclerosis, is the 
highest underlying factor.(18, 19) There are a wide variety of biological vascular conduits 
available for coronary artery bypass grafting (CABG).(18, 20, 21)  The most commonly used 
arterial conduits are the right and left internal thoracic and radial arteries, less commonly the 
right gastroepiploic artery and occasionally the ulnar artery, splenic artery, and inferior 
epigastric artery may also be used.(20-22) The greater saphenous vein (GSV) is the most 
abundantly used venous conduit.(23-25) 
Peripheral arterial disease (PAD) involves arteries distal to the heart, supplying the legs, 
stomach, arms and head, which are narrowed due to atherosclerosis, leading to decreased 
tissue perfusion.(23, 24)  Vessels to the lower limbs are most commonly targeted and large 
calibre arteries, such as aorto-iliac disease, favour prosthetic grafts for reconstruction of the 
vessel and reconstitution of distal flow.(23)  Saphenous veins or commercially available 
synthetic grafts function well in these anatomical regions.(21, 23, 25)  Prosthetic graft 
performance as small vessel conduits are poor.(7, 25, 26)  This include the regions found in 
infra-inguinal bypass, where vessel diameters are less than six millimetres.(6, 24, 25, 27) 
The global burden of CAD and PAD is worsened by the increased rise of diabetes mellitus, 
leading to target organ damage and additionally adding to the amount of patients that develop 
end-stage renal disease.(7, 26, 28) . This disease risk profile adds to the higher numbers of 
surgical procedures performed to establish a vascular access port allowing for 
haemodialysis.(7, 29)  Arteriovenous vascular access in dialysis patients, are prone to develop 
complications such as infection, pseudoaneurysm formation and occlusion due to thrombosis, 
to name but a few, requiring repeat procedures and additional vascular conduits.(7, 30)   
The abovementioned medical conditions contribute to the significant vascular burden of 
disease in society and require innovation and continuous pursuit of novel vascular grafts.  The 
ideal bypass conduit in these haemodynamic demanding environments, are arterial 
conduits.(7, 20, 25)  Arterial conduits have an antithrombotic endothelial surface but unlike 
CABG’s, due to lack in length, arterial autografts in PAD are not a viable solution and therefore 
venous conduits are used.(6, 23, 24)  As mentioned, the GSV is the main conduit used for 
both small and medium distal vascular bypass procedures.(23, 25)  Prosthetic vascular 
conduits have good outcomes in vessels with larger diameters, lower resistance and higher 
flow rates.(21, 23, 25)  When a high quality vein is not available, synthetic material used as 
vascular conduits up to the level of the popliteal artery, have acceptable outcomes. (23, 25)  
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Patency of prosthetic grafts below popliteal region, however, have been unsatisfactory.(23, 
25) 
Research has now turned its focus to attempt mimicking the properties of arterial vessels with 
various graft material (e.g. tissue engineering), different graft reconstruction methods (e.g. 
electrospinning) and impregnation techniques with various substances (e.g. heparin) in an 
attempt to develop improved small vessel grafts that deliver long term patency.(26, 31-34)  
When a biological graft, such as a venous or arterial graft described above is not available, 
artificial grafts are used.  
3. Artificial Vascular Conduits 
3.1 Synthetic Grafts 
 
Expanded polytetrafluoroethylene (ePTFE, Goretex ®) and textile polyethylene terephthalate 
(PET, Dacron®) grafts,(21) are synthetic alternatives to autologous grafts, both having low 
success rates as small diameter (< 6mm) vascular replacements.(7, 35)  They are the most 
abundantly available and used synthetic materials with no evidence of superiority of one 
material over the other.(7)  The patency rate of these synthetic materials as conduits in large 
diameter, high flow vessels (>6mm) is equal to that of saphenous vein grafts.(7)  Patency 
declines and these grafts serve as poor conduits in small vessel disease due to 
thrombogenicity and intimal hyperplasia.(25, 32, 35, 36)  They have patency rates of only 25-
40% at 5 years as femoral-popliteal conduits compared to 70% rate of patency found in 
reversed saphenous vein conduits.(7, 23, 35)  There are essentially no non-autologous 
conduits with acceptable patency rates that can be used in the coronary circulation or 
peripheral small vessel bypass.(23, 27)  Synthetic arteriovenous grafts used as vascular 
access for haemodialysis have very poor success rates.(30, 37)  
3.2  Experimental Grafts  
 
Various studies have revealed that polymer nanofibers seem promising for the use in 
fabrication of small-diameter vascular scaffolds.(7, 37-41)  Numerous novel synthetic fibres 
are investigated as feasible alternative materials to be used in vascular graft reconstruction 
for small diameter vessel bypass.  These materials include polycaprolactone (PCL), 
polylactide, bacterial nanocellulose and poly vinyl alcohol (PVA).(39, 40, 42)  Our group has 
developed grafts based on the polymer polyurethane (PU).(21, 22)  PU consists of three 
monomers, namely isocyanate (crystalline), polyol (amorphous) and a chain extender.(21, 43)  
This allows the material to accept a range of physical properties from soft and elastic, to hard 
and rigid.(21, 43)  PU is generally degradation resistant but by adding a certain polyester as 
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the polyol, it becomes biodegradable and allows for faster endothelialization and less intimal 
hyperplasia, currently making it an appealing experimental conduit for small diameter vascular 
access.(43, 44) 
3.3  Biodegradable Synthetic Scaffolds 
 
The initial attempt to develop a tissue engineered vessel (TEV) replacement in vitro, was 
recorded in the late nineteen hundreds and this research became the stepping stone of further 
developments.(45)  Biodegradable scaffolding is the process of tissue engineering which 
combines a degradable polymer with biologically active material to construct a composite 
matrix.(31, 32)  Polymers give structural stability to the biological materials and gels act as a 
delivery system for biologically activated substances.(46)  The vascular graft is fabricated from 
a biodegradable polymer.  The polymer slowly degrades giving the seeded cells time to form 
an extracellular matrix.(32)  Tissue engineered vessels need to be transplantable and 
withstand circulatory pressures without adverse formation of aneurysm or rupture with 
leakage.(27)  Vessels produced need to be free of immunological degradation once implanted 
and have anti-thrombogenic properties. (27)  These engineered vessels need to be rapidly 
reproducible at clinically relevant scales.  
3.4 Biological Scaffolds 
 
This process makes use of decellularization and recellularization matrices in the absence of 
synthetic tissue to copy the extracellular structure of a vessel.(32)  The scaffold promotes the 
ingrowth of fibroblasts and smooth muscle cells from adjoining tissue into a cellular depleted 
matrix after implantation.(32, 47, 48)  This cellular depleted matrix gradually reconstructs itself 
from the allograft into an autogenous, self-renewed life bearing tissue.(32)  Methods of 
decellularization regimens keeps the microvascular basement membrane of the extracellular 
matrix scaffold intact, maintaining the structure of the vessel so that recellularization can occur 
on the fixed matrix(27, 32)  The use of gel-based endothelial recruitment methods seem to be 
the most promising, along with the decellularization-recellularization strategies, in an attempt 
to achieve microscopic vascular perfusion of TEV.(27, 32)  In addition to the above methods, 
the era of microfabrication of vessels are also in early stages of development and use.(47) 
 
To overcome the difficulties entailed by the transplantation of autologous vessels or synthetic 
conduits, tissue engineering and scaffold generation procedures represent newer techniques 
to attempt to create living conduits with features similar to autologous vessels.(26, 33, 48)  
These novel techniques of neoartery formation with biodegradable tissues and in vitro studies, 
take time and prolonged experimental implantation in animal models are required.(7) 
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4. In Vivo Animal Implants 
 
With the development of medical devices or conduits, translation to clinical implantation in 
humans is preceded by animal models.  In order to resemble and mimic human anatomy, 
pathology and physiology, a living functional cardiovascular system is needed.(49) This is 
particularly crucial in vascular research to asses flow and thrombogenicity.(21, 49)  Animal 
models are cheaper, easily available, and can develop a pre-programmed desired pathology 
as well as mimic the vascular physiology of humans.(49)  No ideal animal model exists to 
assess the various parameters and physiological stressors needed in the preclinical research 
of in vivo vascular conduit experimentation.(2, 49)  Different species and strains are used to 
assess various variables in the methodology and function of vascular graft development.(6, 
49)   
Mice are the ideal animals used in assessing molecular pathways, due to the ease of access 
of varying populations of knock-out species.(34, 49)  However, mice are not ideal for the use 
in vascular graft models, due to their small size, which makes the length of implantable grafts 
suboptimal.(34)  Rats and rabbits, slightly larger rodents, allow for longer vascular implants 
and are therefore more suitable models for proof of concept studies, but are in turn limited by 
not having the knockout effect.(34)  Rabbits are superior to rats in assessment of vascular 
thrombogenicity, due to greater similarities in haemostatic mechanisms such as 
thromboplastic and fibrinolytic properties, when compared to humans.(49)  An additional 
similarity to humans, rabbits also resemble endothelisation of vascular conduits in the 
perianastomotic regions.(43, 49)  Rabbits, however, are disadvantaged by having an 
increased risk of developing paraplegia after infra-renal aortic clamping for placement of aorto-
iliac conduits.(34)  They also present with a wide variation in patency of vascular grafts in 
various implantation locations, presenting with difficulties in finding consensus when 
determining the region of implantation.(49) 
Larger animal models, including sheep and pigs, are more appropriate in relating to human 
vasculature due to the similarities in size of vessel and shear stress of vessel walls.(34, 49)  
Other large species have significant variability when compared to humans, especially with 
regards to the coagulation cascade.(49)  The former holds true in the canine model, where 
studies have shown a tendency towards a hypercoagulable state, with increased platelet 
aggregation, clearly not being an ideal feature in vascular graft studies.(49-51)  Another 
concerning feature is the high patency rate and rapid endothelialization of vascular synthetic 
grafts in dogs with little or no signs of intimal hyperplasia, which does not translate into clinical 
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findings in humans.(25, 34, 43)  Dogs, though easy to handle, are therefore a poor model to 
use in vascular studies.   
The pig model is known for the responsive nature of its vasculature and is at present the 
preferred breed for in vivo experimentation of balloon angioplasty techniques and coronary 
stenting.(49) It is ideal for coronary studies, to assess the rate of restenosis of vessels but 
may also be useful for research of more peripheral vasculature such as the carotid arteries (8, 
11)  In contrast to humans, baboons, dogs and pigs are all able to develop an endothelial layer 
on the luminal surface of an arterial conduit.(25, 34)  Non-human primates are the most 
accurate vascular model, being most similar to humans, even in terms of coagulation, but high 
cost, and ethical concerns limit their use in laboratory research.(25, 49)  There is variation in 
the amount of intimal hyperplasia that develop during vascular graft studies  in animals and 
an increased intimal response is most pertinently observed in pigs.(49) There is less of a 
intimal response noted in primates and rabbits and intimal hyperplasia is almost non-existent 
in canines.(49) Therefore the pig model is known to develop stenosis of vessels six times 
faster than in humans, and is therefore a poor model to assess long term patency of vascular 
grafts.(34)  
Sheep, in turn, have high vascular occlusion rates but restrict endothelisation only to regions 
around the anastomoses of the graft, thus having similarities to the human physiological 
reaction to vascular conduits.(34, 49)  This makes it the preferential animal of choice for 
research involving  physiological mechanisms of vascular graft implantation.(49)  It does 
present some differences of thrombogenicity when compared to humans, and has an 
increased rate of calcification.(25, 49)  Sheep are the large animal vectors of choice to use in 
vascular graft research particularly involving vessels larger than six millimetres in 
diameter.(34, 49) 
Rodents like rats and rabbits are the small animals of choice used in vascular graft 
experiments.(49)  Rabbits are preferred in experiments with vascular conduits up to four 
millimetres in diameter. (49) They also present with the advantage of allowing for bilateral 
implantation of conduits due to longer vessels in their hind legs.(34, 49) Rabbits have a greater 
similarity than rats to humans with regards to physiological parameters such as the 
coagulation cascade, the extent of endothelialization and rate of patency of vascular 
conduits.(34, 49) The difficulty in the smaller rat model arises with perianastomotic 
endothelisation, which presents as a problem in grafts limited to 10mm in length.(49)  Conduit 
lengths of at least 20mm is required to avoid endothelisation resulting from mere 
perianastomotic ingrowth but this length of implant is rarely possible in these models.(49)  Our 
unit has overcome this difficulty by looping the infra-renal vascular graft allowing implantation 
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of grafts up to 100mm in length.(22) Controversially, rats can be used to assess intimal 
proliferation, which is magnified in this model, and is furthermore used to assess strength and 
healing of vascular graft conduits.(22, 49) The advantages of rats in vascular graft research is 
that they have systolic blood pressures similar to that of humans, exposing the graft to 
adequate pressures and the faster heart rates allow for multiple cycles of high pressure 
flow.(21)  Rats are also easy to house and handle, readily available and are considered as an 
adequate low-cost, high throughput model making them ideal for multiple vascular graft 





Ultrasonography is a diagnostic tool widely used in visualizing soft tissue and organs in both 
medical and veterinary fields.(3)  Ultrasound produces images as sound waves come into 
contact with tissues of varying density.(52)  The earliest documented application of ultrasound 
was introduced by Dussik in 1942. (1) The first application of this modality involved imaging 
the brain, the abdomen for gallstones, obstetric use and eye assessment in ophthalmology. 
(1, 53)  Initial examinations were made using A (Amplitude) Mode with patients immersed in 
water.(1)  Contact ultrasound with transducers directly applied to the patient’s skin, was first 
developed in Glasgow in the 1960’s.(1, 53)  The sound waves produced by a transducer, pass 
through tissues of varying densities with different acoustic impedance.(6, 52)  The different 
densities of tissue that the sound wave encounters is recorded as an “acoustic impedance 
mismatch”,(52) and these sound waves are conducted back and interact with crystals on the 
ultrasound transducer.(3, 36, 52) This produces a current of electrical signals interpreted 
through computational analysis, processed and displayed on the screen.(6)  This allowed for 
the development of B (Brightness) Mode which produces a grey-scaled, two-dimensional 
cross sectional image in real time.  Moving structures can be analysed due to the development 
of real time imaging using M (Motion) Mode ultrasonography.(1, 2, 54)  The assessment of 
blood flow, however, has only been made possible with Doppler ultrasonography where 
velocity of moving tissue is determined.(6)  
 
5.2 Small Animal Models 
 
In the premillennial era, ultrasonographic imaging in laboratory research was restricted to large 
animals.(4, 6, 55)  Ultrasound imaging techniques in animals have been adapted from human 
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diagnostics methods, but there is an increased demand for improved spatial and temporal 
resolution in imaging of smaller animals due to the limitation in their size and high physiological 
demand with extremely rapid heart rates.(2, 6, 10)  Developments in ultrasound imaging has 
led to commercially accessible, advanced ultrasound systems with transducers that accurately 
interpret spatial and temporal resolution to acquire adequate imagery of vascular structures of 
rats and mice.(2, 6, 10) 
 
In rodents both increased spatial (consisting of axial and lateral) resolution and temporal 
resolution is essential for adequate imaging.(6, 10)  Axial resolution is defined by the 
proficiency in determining the presence of two detached but closely related structures lying 
parallel to the ultrasound beam.(6)  Axial resolution is amplified with sound waves of  increased 
frequencies.(6)  Lateral resolution is defined by the ability to determine that  two closely related 
structures are separate, lying perpendicular to the beam, a parameter which improves by 
narrowing the ultrasound beam width.(6)  Both these parameters increase in accuracy with 
higher frequencies emitted from the transducer.(6, 52)  Temporal resolution alludes to the 
capability of ultrasound to discern between two events at differing time frames and is 
calculated as the amount of image frames acquired per second.(6) Temporal resolution plays 
an important role in imaging moving structures like the heart in small animals with very fast 
heart rates.(6, 10)  The limitation of higher frequency probes is that the higher the frequency 
of the probe, the lower the penetration depth of the sound wave, therefore giving a clearer 
image by improving lateral and axial resolution but making deeper structures difficult to 
visualize.(6) This, however, does not affect the transducer selection in small animals, since 
transducers with frequencies of up to 10MHz can penetrate as deep as 50mm, which is an 
adequate depth of penetration in rodents.(6, 10)   
 
The difficulties in conducting ultrasound evaluation in small animals versus large animals are 
clearly defined.(2, 6)  Limitations in large animal screenings are related to the depth of 
imaging, with most transducers not having adequate penetration depths beyond 25cm.(2)  In 
small animals the depth of imaging is less of a problem, but difficulties arise in separating 
various tissue planes.  Faster heart rates, the need for anaesthesia and the decrease in body 
temperatures, which may result in haemodynamic instability during ultrasonography, also 







5.3 Vascular Ultrasonographic Imaging 
 
Doppler ultrasonography is a less invasive diagnostic technique used in determining vascular 
flow and patency of vessels in humans and animals.(10, 11, 52)  The direction of blood flow 
and velocity is determined on spectral and colour flow Doppler modalities by using the 
“Doppler shift principle”.(6, 10, 52)  The variation in sound wave frequencies that ensues when 
the waves are reflected by mobile objects, including blood cells, is described as the “Doppler 
Effect”.(6, 10)  The discrepancy between the transmitted and reflected sound wave frequency 
is termed the "Doppler Shift".(6, 52)  Spectral Doppler consists of pulse wave and continuous 
flow Doppler ultrasound.(6, 52) Pulse wave Doppler displays velocity measured at a single 
point whereas Continuous flow Doppler allows you to measure velocity continuously and 
dynamically along an entire line.(6, 52)  Colour flow Doppler in turn, displays the route of the 
blood flow and the velocity of flow in a vascular structure in real time and can be used to 
evaluate turbulence in vessels.(6, 8, 10)  Doppler ultrasonography is particularly useful in 
assessing the flow characteristics within vascular structures, including the heart.  It is affected 
by the direction of the flow of blood in association with the ultrasound beam and may 
erroneously attenuate flow measurements if the ultrasound beam is not parallel to blood 
flow.(10)  Higher resolution Doppler imaging modalities have become a popular technique in 
assessing vascular physiology.(10, 56)  
 
5.4 Application of Vascular Imaging in Laboratory Research 
 
Doppler ultrasonography has been used in determining flow in vascular grafts as early as 
1981, where an assessment in patency and flow of PTFE vascular grafts in humans was 
facilitated by Doppler blood flow measurements.(57)  In this earlier study, PTFE grafts did not 
transmit the ultrasound beam adequately to evaluate flow within the graft.(57)  It was thus 
erroneously concluded that Doppler ultrasonography measurements over PTFE grafts were 
not detectable and ultrasound could not reliably be used to assess flow in the early post-
operative periods.(57)  This study, however, was soon followed by others, where Doppler was 
able to accurately differentiate between ligated femoral arteries in rats and ePTFE interposition 
grafts up to one millimetre in size.(58)  It allowed for a 100% accuracy at 20 days of 
implantation, but this accuracy did, however, decrease at 24 weeks.(59)  
In similar research conducted in large animal models, inaccuracy of Doppler findings seems 
to be less of a problem.  Doppler ultrasonography was found to be more accurate when used 
to evaluate patency or occlusion of implants in carotid arteries in pigs at different time frames, 
compared with the gold standard, namely angiography.(9, 11)  At four week follow-up in this 
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study the negative predictive value (NPV) was still as high as 95%, positive predictive value 
(PPV) of 92%, sensitivity of 86% and specificity of 92% in determining patency with 
ultrasonographic imaging of carotid grafts in pigs.(11)   
The use of Doppler ultrasonography in assessing the stenosis and flow velocity in carotid 
arteries is common and has been used in small animal models as well.  Doppler 
ultrasonography has been utilized in diabetic Long-Evans rats, to determine common carotid 
arterial blood flow velocity and colour Doppler sonography, detecting significant carotid artery 
stenosis.(14, 16)  Various studies have been reported to use Duplex Doppler modalities in 
accurately assessing the level and severity of carotid artery stenosis in rats.(16)  Accurate 
assessment of the level of occlusion, with stenosis ranging between 30-85% of the diameter 
of carotid arteries of rats could be detected and evaluated.(16)  Colour and pulsed wave 
Doppler modalities are utilized to determine flow turbulence, M-mode measures the vessel 
cross-sectional dimensions and B-mode is used to determine vessel length.(15)  
Ultrasonography was able to assess three intricate graft manipulations in carotid vein grafts 
in mice, with turbulence, cross sectional dimensions and length of vessel measured with above 
modalities.(15)  All results were accurately reproducible when compared to histology ex-
vivo.(15) 
The first reported ultrasonographic imaging of abdominal aortic aneurysms in mice, was 
recorded in 2001.(8)  There has been significant development of ultrasound imaging 
modalities since, and ultrasonography has been used to evaluate progression of abdominal 
aortic aneurysms in rats.(8, 60)  Measurements including assessment of vessel stiffness and 
diameter of the aneurysmal segments of the aorta can be detected on Doppler imaging.(13)  
Pulse wave Doppler is used to determine changes in velocity and high-frequency ultrasound 
can be used to characterize abdominal aortic aneurysm progression and thereby contribute to 
increased understanding of aneurysm pathogenesis.(8, 60)  Due to the progression and 
development of high frequency ultrasound images that provide better spatial resolution, it has 
been possible to accurately quantify and measure aortic diameter and wall thickness in mice 
and rats. (8) Transducer probes are continuously improving and more intricate parameters 
such as heart rate, peak ascending aortic velocity, aortic diameter, left ventricular ejection 
fraction and cardiac output can be accurately determined. (56, 61, 62)  
In the past five to ten years there have been developments with regards to ultrasonographic 
technology in animal research, especially small animal models.  Ultrasound is an attractive 
diagnostic modality since it allows for long term follow up, without additional harm to animals. 
However, in studies conducted as recently as 2018, it is still only used as one of three 
modalities to determine patency in vascular graft models.(42)  The gold standard in 
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determining patency still accepted as angiography, followed by histological assessment.(9)  
Even in studies with MRI and CT angiography available, both modalities could only confirm 
patency at explant.(42)  These imaging modalities are not readily available in all research 
units.  Even though Doppler ultrasonography is utilized in vascular graft studies as an imaging 
modality, it is not used to determine time of explant of grafts.  Patency is only confirmed by 
invasive measures during termination of the study at explant. 
The implantation of small-diameter electrospun interposition grafts in the rat aorta, were 
assessed for patency at one and three months by using only high frequency colour Doppler 
ultrasonography.(6, 39)  Assessment of flow velocity at proximal, distal and the centre of the 
graft was made. Ultrasound adequately indicated patency of all grafts implanted and this was 
confirmed on histological assessment.  No mention of angiographic evaluation was made.  All 
grafts were deemed patent at three months with only the use of Doppler ultrasonography and 
confirmed on histological assessment after explant.(13, 39) 
In similar studies with silk interposition grafts implanted in the female rat aorta, patency was 
also only assessed with Doppler ultrasonography and obstruction of grafts were detected on 
Doppler ultrasound.(44, 63)  The presence of aneurysm formation, thromboses and aortic 
diameter was recorded.(8, 44)  The occluded grafts were evaluated with ultrasonography and 
confirmed to be occluded prior to explant with a hundred percent specificity and sensitivity for 
detection of graft occlusion and patency on ultrasonography.(13, 44) 
6. Summary 
 
Our unit has conducted studies looking at transmural ingrowth in implanted vascular grafts in 
rat models. (21, 43) We have found that by looping the graft, one achieves a broad endothelial 
surface to assess transmural endothelialization more accurately over longer time frames than 
when compared to straight grafts.(21, 43)  Although technically more challenging, making use 
of a loop graft instead of standard straight implants allows for more length so that the 
anastomoses is at a distance from the isolated mid-graft segment.  Results of studies 
previously conducted, validated the loop graft to be a high output model for evaluating the 
isolated healing of the mid-graft segments in vascular conduits.(43)  Due to advances in 
ultrasound imaging technology, it is being used more frequently as a diagnostic tool and we 
would hope to use this modality in the assessment of occlusion or patency in our complex 
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Introduction: Intensive research over the last six decades has resulted in minimal 
improvement in vascular graft development.  Small animal models are the first line of species 
exposed to vascular graft implantation and invasive monitoring of experimental graft patency 
may contribute to pain, suffering, higher cost and earlier sacrifice.  Non-invasive 
ultrasonographic evaluation of vascular implants during the conduction of animal studies 
allows for chronic follow-up with multiple assessments.  This study aims to apply and endorse 
the utilization of ultrasound as a less invasive diagnostic method in determining patency of 
vascular grafts in units where imaging modalities like Computerized Tomography (CT) and 
Magnetic Resonance Imaging (MRI) are not readily available. 
 
Methods: Pre-operative control ultrasound evaluation of the ejection fraction, aortic diameter 
and aortic velocity were conducted on Wistar rats (250-350g).  Infra-renal aortic vascular graft 
implantation was then performed, with 8 rats receiving straight (1.8mm ID, 18mm length) 
expanded polytetrafluoroethylene (ePTFE) grafts, while 12 rats received a long (1.8mm ID, 
100mm length) looped ePTFE conduit with a sealed mid-graft (10mm length) section.  
Ultrasonography was conducted on days 1, 3, 7 and weeks 4, 8 and 12 post operatively.  
Grafts were explanted if there was any ultrasonographic evidence of occlusion or at twelve- 
week termination of the study.  Explant was preceded by angiography and followed by 
histological assessment of the grafts for patency.  
 
Results:  Three of the looped and all 8 of the straight grafts were patent at the 12 week explant 
time point, as correctly assessed by ultrasound and confirmed by angiography and histology. 
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Three of the nine occluded looped grafts were explanted at eight weeks due to early 
ultrasonographic detection of occlusion; the remaining 6 were explanted at twelve weeks. 
There were two false positive results, which were incorrectly assessed as patent at twelve 
weeks of implantation on ultrasonographic evaluation, but confirmed to be occluded on 
angiography at explant.  The results of ultrasonography evaluation of implanted infra-renal 
vascular grafts had a high specificity of 100% with a sensitivity of 78%.  The outcome of the 
results between ultrasound and angiography corresponded in 18 out of 20 vascular grafts, 
with a calculated positive predictive value (PPV) of 100% and a negative predictive value 
(NPV) of 85%. 
 
Conclusion: Ultrasound is easily available and a non-invasive diagnostic modality allowing 
for safe and reliable results, which may be repeated at different time frames following vascular 
implants in small animal models.  Ultrasonographic limitations exist, emphasizing the need for 
an experienced operator with adequate knowledge and training.  Its use may be complicated 
by tortuous geometries of vessels, which is technically more challenging to evaluate with 
ultrasound than with imaging techniques like CT and MRI.  It does, however, add information 
without additional loss of life or increased use of animal numbers.  Ultrasound is an essential 







Ultrasound includes any sound frequency above the human audible range (20kHz) and the 
process of ultrasound imaging utilizes a transducer containing piezoelectric material which 
vibrates.(1, 2)  These vibrations emit high-frequency sound waves, colliding with tissue as an 
acoustic interface.(3)  A portion of the sound wave is reflected back as a measurable voltage 
detected by the transducer.(1, 2, 4, 5)  If the tissue interface that the sound wave collides with 
consists of two varying densities, different voltages will be reflected back and this phenomenon 
is known as an “acoustic impedance mismatch”.(2, 3, 6)  Diagnostic ultrasonography relies on 
the “Pulse-Echo principle”,(2, 7) where measuring the time between the transmission of the 
impulse and the reception of a given echo signal, allows for the construction of a two 
dimensional anatomical image.(1, 2)  By knowing the speed of the sound and time taken for 
the sound waves to return, the depth of the tissue the echo is reflected from, may be 
calculated.(2, 7)  This input is converted to interpretable images on the monitor through a 
computational algorithm.(2)  Ultrasonography allows for the interpretation of tissue structures, 
flow dynamics and function, and has been used for decades in clinical medicine and is now 
more often being applied to research in the laboratory setting.(1, 7) 
 
Ultrasound imaging methods applied in small animal research have been adapted from clinical 
human diagnostic applications.(7)  The faster heart rates and smaller anatomy in rodent 
models increase the demand for the better quality of spatial and temporal resolution.(3, 7)  
Imaging techniques and equipment have been modified and enhanced to meet the demands 
of these higher-resolution requirements.(3, 7, 8)  There is an improvement in spatial resolution 
with an increase in frequency and higher frequency transducers have been produced, which 
has allowed for accurate quantification of the vascular dimensions in mice and rats.(3, 9) 
 
The “Doppler Effect”,(2, 3) is used to describe the motion of the sound impulse which is 
reflected from a moving target.(3)  This impulse is deflected either towards or away from the 
transducer, with higher frequencies observed from structures moving towards the transducer 
and lower frequencies from those moving away, this is known as the “Doppler Shift 
Principle”.(3, 7)  Doppler signals can be displayed as colour Doppler with “colour flow 
mapping” or be presented as “velocity profile over time” known as spectral Doppler.(2)  Higher 
resolution Doppler systems are frequently used in evaluating human and animal vascular 




This diagnostic modality applied in animal research, influences laboratory studies involving 
vascular conduit production, allowing non-invasive and continuous monitoring of progress 
without early or unnecessary sacrifice of animals.(9, 11)  Small animal models are considered 
to be the low cost and high throughput model of choice in the initial analysis of vascular grafts. 
Pre-clinical research aims to develop vascular graft materials that mimic the structure and 
function of autologous arteries.(12)  These grafts may be of use in human recipients who do 
not have sufficient autologous conduits to treat coronary artery disease, peripheral vascular 
disease or to provide vascular access for renal dialysis.(6, 12) 
 
For the past six decades, intense research has been conducted in an attempt to create small 
diameter vessel conduits that translate into clinically acceptable autologous, vascular 
substitutes.(12, 13)  Expanded polytetrafluoroethylene (ePTFE, Goretex ®) and textile 
polyethylene terephthalate (PET, Dacron®) grafts, (14) are alternatives to autologous grafts.  
Both these synthetic materials have high failure rates when used in narrow diameters (< 6mm) 
as small vessel replacements.(12, 15) 
 
Our laboratory has previously shown that straight infra-renal ePTFE grafts have confirmed 
long term-patency, whereas looped grafts with non-porous test segments are more prone to 
early occlusion.(16)  Invasive methods may be used to determine patency, but these have 
significant consequences.(9, 11)  In animal research, invasive monitoring may contribute to 
pain, suffering, higher cost and earlier sacrifice of animals due to humane end points being 
reached.(9)  Non-invasive use of ultrasonography during vascular implants in animal studies 
allows for chronic evaluation and follow-up of these models.(9)  Assessment of the accuracy 
of implementation of ultrasound evaluation of our unit’s vascular grafts, could add additional 
information to vascular research conducted and a means of refinement and reduction of 




2. Materials and Methods 
 
2.1  Study Design 
 
The protocol was approved by the Animal Ethics Committee (AEC) of the University of Cape 
Town (UCT) (protocol AEC 017008) and performed in compliance with “the Guide for the Care 
and Use of Laboratory Animals, Institute of Laboratory Animal Resources, Commission on Life 
Sciences, National Research Council and ARRIVE guidelines.  The surgical procedures and 
ultrasound investigations were performed by personnel accredited by the South African 
Veterinary Council (SAVC). 
 
Ultrasonography was performed on Wistar rats (250-350g).  A control group (n=10) underwent 
pre-operative ultrasonographic assessment of the aorta and heart to measure abdominal 
aortic flow, flow velocity, aortic diameter and ejection fraction.  The experimental phase 
consisted of 20 Wistar rats divided into two groups for infra-renal aortic vascular graft 
implantation.  Group 1 (n=8) received an 18mm length of ePTFE straight graft implant.  Group 
2 (n=12) received a 100mm looped graft implant consisting of a 90mm ePTFE conduit with a 
10mm sealed mid-graft polyurethane section.  
  
Figure 1: Schematic Presentation of Methodology 
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2.2  Graft Production 
 
2.2.1  Polyurethane (PU) Mid-Graft Segment Construction 
 
The mid-segment of the loop graft was constructed as previously described.(14)  Briefly, a 
porous cylindrical cast was produced by tightly stacking gelatin beads in a glass mould around 
a centrally located mandrel and applying a 10% PU solution.  The remaining voids were filled 
by providing a driving pressure (750 kPa) to the solution with an additional downstream 
external vacuum (100 kPa).  
The cylindrical casting was demoulded from the tube, and the polymer phase inverted for 24 
hours at room temperature with 96% ethanol.(14)  The gelatin beads and additional solvent 
were washed from the polyurethane in a water solution at 60 degrees Celsius over five days, 
and dried to produce a tube with well-defined interconnected porosity.(14)  The resulting 
cylinders were cut into 1cm segments and used to form the mid-portion of the loop graft. 
2.2.2  Loop Conduit Construction 
 
A 33 cm long nylon cord was tightly wound around a plastic rod (1.5mm [OD]) and secured 
with cable ties and subsequently placed in boiling water for six minutes.(14)  Following rapid 
cooling, the cord was unravelled in its heat-set form and then cut into 11 cm segments.  Each 
curved segment was used to construct a loop graft.  A one centimetre bevelled PU mid-graft 
segment (described above) was placed in the centre of each 11 cm nylon cord.  Two ePTFE 
graft segments measuring 4,5cm in length, were fed onto the nylon cord and glued to either 
end of the bevelled PU mid-graft segment.(14)  This construction formed a 10cm looped graft. 
The abluminal surface of the PU mid-segment of each looped graft was coated with a 10% 




Figure 2: Loop Graft Construction (A) Displays a 33cm long nylon cord (1.5mm [OD]) 
wound tightly around a 15mm cylindrical rod and secured with cable ties.  (B) The nylon cord 
is divided into 11cm long segments with a mid-graft PU segment fed onto the nylon cord and 
the two ePTFE graft segments glued to either side of the PU segment.  The PU segment is 




2.3 In Vivo Implantation of Grafts 
 
An inhalational mask induction anaesthesia with Isoflurane (5%) at 1.5l/min was used.  A 
midline laparotomy was performed under strict aseptic conditions and the infra-renal aorta was 
dissected to display the left renal artery cranially and the aortic bifurcation with iliac vessels 
caudally.  The iliolumbar branches were cauterized, aorta mobilized and heparin (1mg/kg) was 
injected via the iliolumbar vein.  Following proximal and distal clamping, the infra-renal aorta 
was transected in a bevelled fashion, without excision allowing for enough aortic length for 
manipulation of the straight and the loop-grafts segments during implantation.   
 
Graft conduits were cut to the required size and a thin arterial guidewire (Arrow® Seldinger 
Arterial Catheter, North Carolina, US), was introduced through the graft lumen into the 
proximal or distal lumen of the aorta.  The guidewire was held in place temporarily in the 
proximal and then distal aortic lumen with an arterial clamp, to separate anterior and posterior 
vessel walls.  This technique was used as a preventative measure to avoid suturing both 
arterial walls together during the anastomoses, which would lead to the obstruction of the 
vessel lumen.  The guidewire was removed once four sutures had been placed, one at each 
corner of the graft proximally and then distally, ensuring a patent lumen.  Once the guidewire 
was removed the anastomoses of the graft to proximal and distal abdominal aorta were 
completed with 9-0 nylon (Johnson & Johnson, New Brunswick, NJ), in a total of ten to twelve 
interrupted sutures.  
 
The graft was de-aired by first releasing the distal clamp, filling the graft with blood, followed 
by the slow release of the proximal clamp.  The anastomotic sites were compressed until 
haemostasis was achieved.  Looped grafts were buried in the retroperitoneal space.  A 
patency test of the graft was performed under vision with a distal compression technique and 
ensuring both hind limbs of the rat was well perfused before closure.  The midline laparotomy 
was closed with 2-0 Ethibond (Johnson & Johnson, New Brunswick, NJ) sutures in layers.  
During the recovery phase, the rats were isolated in separate cages for the first 24 hours and 
given softened food and water. Once recovered they were transferred back to cages with 
fellow rats for social interaction.  Pain was controlled post-operatively with subcutaneous 
injections of buprenorphine (0.05 mg/kg) three times daily for 72 hours, or until no features of 




2.4  Ultrasound Examinations 
 
Ultrasonography was conducted by two of the researchers (NDS; NH).  All the results were 
cross-evaluated by both to standardize findings.  This procedure took place on day 1, 3, 7, 
week 4, 8 and week 12 post operatively.  A single dose of buprenorphine (0.05mg/kg) was 
administered as premedication 30 minutes prior to induction for Ultrasonography.  The animals 
were induced with isoflurane at 5% in a transparent anaesthetic chamber and while 
spontaneously breathing, maintained on 1.25% on nose cone after being transferred supine 
onto a heated platform with integrated electrocardiogram, allowing for heart rate, breathing 
rate and temperature monitoring.  
 
The area of incision was carefully shaved with an electric razor.  Hair removal was further 
achieved with dilapidating cream (Nair® Hair Removal Cream, New Jersey, US) applied over 
precordial chest and abdominal incision site.  After about one minute, the cream was wiped 
off the animal with dry gauze, and finally wiped with warm saline soaked gauze to prevent skin 
irritation.  An electrocardiogram (ECG) was obtained by applying electrolyte gel to all four 
paws of the rat and secured with adhesive tape.  A temperature probe was inserted rectally, 
to monitor any loss of temperature during the procedure.  A 3mm layer of ultrasound 
conducting gel was applied on the prepared area for ultrasonography.  Ultrasound studies 
were conducted with a linear MS 250 probe (Fujifilm VisualSonics ®, Toronto, Canada) with a 
resolution ranging from 13-24 MHz, using the Vevo 2100 ® (Fujifilm VisualSonics ®, Toronto, 
Canada) with a 30 micron resolution and 740 fps.  
  
A B 
Figure 3: Ultrasonography Setup (A) Vevo 2100 ® with heated 
platform and respiratory monitor (B) Rat induced with isoflurane, in a 
supine position on a heated platform with integrated 
electrocardiogram, ultrasound probe and temperature probe. 
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2.5 Image Acquisition  
 
The probe was held at 90 degrees to the abdominal surface of the rat, traversing the aorta in 
a set of sweep images obtained from cranial to caudal over the abdominal incision site.  The 
images of the aorta in transverse view and its branches serving as landmarks were acquired, 
optimized and captured for measurement of aortic diameter.  The probe was then rotated 
clockwise 90 degrees for measurement of velocity in the long axis.  To optimize the image, 
maximized colour and power gain was used in greyscale, colour and spectral modalities to 
avoid aliasing or background noise.  Under these standard conditions, if any inadequacies of 
flow measurements were present, further alterations were made to gain quality.  To visualize 
adequate 2D images of the ventral and dorsal walls of the aorta and the vascular graft, the 
gain was adjusted accordingly.  The walls of the graft and vessels was depicted by Doppler 
colour flow inside the graft with an echo/free space inside the graft, indicating patency.  Pulse 
wave Doppler velocity was conducted by selecting an angle of insonation less than 60 
degrees, this was to minimize error between the true velocity and measured velocity as related 
to the cosine of the angle of insonation.  The proximal and distal aortic flow velocity was then 
measured with pulse wave Doppler, proximal and distal aortic diameter measured in M-mode 
and presence and type of flow (triphasic/biphasic/monophasic) was assessed with pulse wave 
Doppler ultrasound evaluation and recorded. 
 
On completion of the investigation, US gel was wiped from abdomen and the animals were 
placed back in their cages and monitored in a warm environment until awake and ambulating. 
Immediate termination of the study, with graft explant, was performed if there were any 
features suggestive of graft occlusion during ultrasound.  A narrowed lumen of the graft or 
aorta at the level of the anastomoses, in the absence or presence of turbulent colour flow on 
Doppler evaluation, was defined as a stenosis.  The presence of a thrombus in the graft lumen, 
depicted as a large 2D hyperechoic lesion on ultrasonography, without the presence of flow 
on Colour Doppler was defined as an obstructed graft.  The graft was considered to be 
occluded if there was no colour flow detected in the graft, no distal lumen present and in the 
absence of triphasic flow distally.  The study was immediately terminated, irrespective of 
duration of implantation, if any of the above features were present.  If the graft was deemed 
patent on Doppler ultrasonography, the study was only terminated at 12 weeks of implantation 










Figure 4: Ultrasonography of Grafts (A) and (B) showing the cross section and the 
longitudinal section with graft anastomoses, of the proximal abdominal aorta, respectively. 
(C) and (D) indicating the cross sectional diameter of the lumen of proximal and distal aorta 
measured in M-Mode, respectively. (E) The proximal and distal aortic flow velocity 
measured with pulse wave Doppler and the presence and type of flow (triphasic) assessed 
with colour and pulse wave Doppler ultrasound evaluation. (F) Showing distal abdominal 





Standard assessment of cardiac parameters and function were mainly acquired from the 
Parasternal Long Axis View (PSLAX) and Mid-papillary Short Axis View. (SAX).  An ejection 
fraction of the heart was assessed in these views and calculated in M-Mode.  
 
 A B 
C D 
Figure 5: Echocardiography Rat Heart (A) and (B) Parasternal Long Axis (PSLAX) view 
and Mid-papillary Short Axis (SAX) view of the rat heart, respectively.  (C) and (D) showing 
an ejection fraction (EF) of the heart performed in PSLAX and SAX views, respectively and 
calculated in M-Mode. (LVAW;d, Left Ventricular Anterior Wall in diastole, LVAW;s, Left 
Ventricular Anterior Wall in systole, LVPW;d, Left Ventricular Posterior Wall in diastole, 
LVPW;s, Left Ventricular Posterior Wall in systole, LVID;d, Left Ventricular Internal Diameter 
in diastole, LVID;s, Left Ventricular Internal Diameter in systole, HR, heart rate.) 
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2.7  Angiography and Explant of Infra-Renal Graft 
 
After 12 weeks or on detection of occlusion of the interposition graft with Doppler 
ultrasonography, the experiment was terminated (earlier if humane endpoints were reached). 
Under general anaesthesia, the last Doppler ultrasonographic evaluation of graft was done to 
determine degree of patency/obstruction of the graft.  Explant of the vascular graft was 
performed under Isoflurane anaesthesia (as mentioned above).  Re-entry of the abdomen was 
via previous laparotomy.  Visual patency test of distal aorta was performed and documented, 
followed by a dose of heparin (1mg/kg) injected into the inferior vena cava (IVC) before the 
animal was euthanised.  
 
Laparotomy was extended into a sternotomy to expose the heart.  An incision was made into 
the right atrium and the animal was exsanguinated.  On apnoea, a 22-gauge cannula was 
advanced trans-apically, via the left ventricle, into the ascending aorta and a single dose of 
5ml iodine contrast solution was given.  A time-controlled x-ray was taken with a C-arm 
(Phillips® BV Pulsera, Massachusetts, US) while injecting contrast medium, which was 
followed through until contrast reached caudal and femoral vessels.  Once angiography was 
complete, a phosphate buffered solution was introduced via the same cannula in the apex of 
the heart, to flush the abdominal aorta and graft.  This process was continued until blood was 
replaced by clear fluid draining out of the right atrium.  Following this, the graft underwent 
perfusion-fixation with 150ml of a 10% formalin solution, and was next excised and sectioned 
to be processed for histology. 
 
2.8  Histological Processing 
 
The 18 mm ePTFE straight grafts were cut with a 5mm longitudinal segment at proximal and 
distal anastomoses and a 5mm transverse midsection through centre of the graft.  The loop 
grafts in turn were cut into 5 segments.  This included a 5mm longitudinal segment at proximal 
and distal anastomoses.  Two 5mm transverse segments proximal and distal to the mid-graft 
polyurethane segment and a 5mm transverse segment through the centre of the mid-graft 
segment were cut.  The graft segments were all fixed in 10% Formalin for histological 
assessments.  The samples were sliced into 6μm sections and Haematoxylin Eosin and Miller 
and Masson’s trichrome stains were performed on these sections for basic light histological 
analysis.  The vascular conduits underwent histological processing to assess the presence of 




2.9 Statistical Analysis 
 
 
All data was imported into JMP statistical software (version 11.0, Cary; NC) for statistical 
analysis.  Results were expressed as mean ± standard deviation (SD) for continuous 
variables. Following a Shapiro-Wilk test for normality, the unpaired t-test was used to compare 
normally distributed data and Mann-Whitney for nonparametric values.  The level of 
significance was set at P < 0.05.  Graphical representation used a lambda smoothing function 
(0.01) to describe the relationship of the scatter plot.  A smooth curve through the scatter was 






Infra renal vascular grafts were implanted in 20 Wistar rats.  Group 1 consisted of straight 
ePTFE grafts implanted in the infra-renal aorta of 8 rats.  Group 2 had loop grafts implanted 
in twelve rats.  Graft patency was evaluated with ultrasound on day 1, 3 and 7 as well as 4, 8 







Figure 6: Ultrasound Comparison of Straight verses Looped Grafts (A) Longitudinal 
section in M-Mode with the entire length of straight graft visualized in a single frame. (B) 
Colour Doppler flow through straight graft.  (C) Calculation of flow velocity in straight graft 
using Pulse Wave Doppler modes.  (D) Shows the longitudinal section through both arms of 
the loop graft in the centre of the graft where both arms cross over.  The entire loop graft 
being too large to visualize in a single frame.  (E) Colour Doppler indicating bidirectional flow 
in both arms of the loop graft.  (F) Cross section through center of the loop graft showing both 




In Group 1, Doppler had a 100% sensitivity for detecting patency and angiography 














Figure 7: Ultrasound Investigation of Patency in Loop Vascular Grafts (A) Loop Graft post 
implantation. (B) Loop Graft just before explant, with proximal (p) and distal (d) anastomoses 
visible (C) Colour Doppler indicating the centre of the loop graft with flow in opposite direction 
in each arm.  (D) Colour Doppler flow in proximal arm of loop (P) and flow in center of the loop 
(L). (E) Part of the loop graft visualized on colour Doppler with distal arm of graft having flow 
in the opposite direction. (F) Colour flow in both lumens of loop graft lying side by side, in cross 
section. (G) Pulse Wave Doppler to determine the velocity in both proximal and distal arms of 





In Group 2 at explant, 9 of the twelve grafts were occluded when compared with angiography.  
Ultrasonography correctly identified 7 of the occluded looped grafts, of which 3 were correctly 
explanted early at 8 weeks.  Two of the nine grafts were, however, incorrectly identified as 









Figure 8: Straight Graft Angiography and Histology Results (A) Straight ePTFE graft 
at 12 weeks implantation with arrows indicating proximal and distal anastomoses, 
respectively. (B) Angiogram with contrast indicating patent straight ePTFE graft at 
explantation, with arrows indicating proximal and distal anastomoses. (C) And (D) 
histological samples of the longitudinal and cross section of a straight ePTFE graft, 
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Figure 10: Obstructed Loop Graft Angiography and Ultrasonography (Second False 
Positive Result) (A) Angiography of occluded loop graft incorrectly thought to be patent, 
with a large collateral vessel (arrow). Vessel supplying good flow to distal Iliac (I), Femoral 
(F) and Caudal (c) arteries. (B) Pulse wave Doppler with measurable velocity with triphasic 











Figure 9: Obstructed Loop Graft Angiography and Ultrasonography (First False 
Positive Result) (A) Angiography of occluded loop graft incorrectly thought to be patent. 
Arrow shows an absence of the infra-renal loop graft conduit due to occlusion, with a 
dense network of collateral vessels and a large filling vessel (arrow) supplying distal iliac 
(I), femoral (F) and caudal arteries (c). (B) Arrow indicating presence of multiple large and 
small collateral vessels, with lumen of graft obstructed.  (C) During assessment of patency 





The remaining 3 of the 12 loop grafts were explanted early for clinical reasons.  Of these patent 
loop grafts, one rat had an embolic event to the caudal artery, which resulted in ischaemia of 
the tail tip, but Doppler still showed patency of the looped vascular graft.  Two animals were 
euthanised for humane endpoints before 12 weeks; and in these three animals the grafts were 






Figure 12 : Patent Loop Graft (A) Angiography of a patent loop graft in infra-renal 
abdominal aorta (AA) with an arrow indicating a proximal filling defect in caudal (c) artery 
possibly leading to distal embolism and tail necrosis. (B) Pulse wave Doppler, detecting 
proximal and distal velocity in the loop graft confirming patency of graft. Indicating patent 
lumen with triphasic laminar flow during pulse wave Doppler.(Vel Velocity) 
 
B A 
Figure 11: Loop Graft Histology Histological sections in 2% glutaraldehyde embedded 
in paraffin and sliced into 6μm in thickness with Haematoxyline Eosin and Miller and 
Masson’s trichrome stain.  (A) Proximal 5mm longitudinal segment of looped vascular 
graft, with patency of the lumen evident on histology. (B) Cross sectional mid-graft 
segment of the same graft indicating obstruction of the lumen.  Histological sections 
indicate difficulties in assessing patency of loop graft segments with some sections being 




Doppler had a 100% specificity and 78% sensitivity to detect occlusion in the 20 grafts 
implanted. The results between ultrasound and angiography corresponded in 18/20 animals 
that had implants performed with a positive predictive value (PPV) calculated at a 100% and 
negative predictive value (NPV) of 85%. 
 
Figure 14: Statistical Presentation of Findings of Ultrasound Ability of ultrasound to detect 
occlusion of implanted straight and looped infra-renal vascular grafts. 
 
 
Figure 13: Graphical Presentation of Study Results Comparison of ultrasonographic 




Miscellaneous Ultrasound and Echocardiography Findings  
Initially ultrasonography evaluation of graft patency was performed directly post surgery. 
Imaging indicated an empty left ventricle indicative of significant hypovolaemia  
Injury of the iliolumbar and sciatic nerves during clamping of the iliolumbar vein lead to a 
neuropraxia in two of the rats.  Ultrasound confirmed that neurological fallout, presenting as a 
unilateral leg lag of the hind leg, was not due to an ischaemic event.  Ultrasound indicated 
good distal flow from aortic bifurcation to femoral arteries. 
 
Figure 15: Left Ventricle Post-Operative Hypovolaemia Echocardiography of parasternal 
long-axis view indicating poor filling of the left ventricle of rat directly post operatively with 





Figure 16: Right Neuropraxia Due to Iliolumbar Nerve Injury (A) Colour Doppler, indicating 
aortic bifurcation into iliac vessels and (B) flow down the left femoral artery in an animal with leg 
lag of left hind leg. Confirming that no ischaemia is present, neurological injury due to 
Neuropraxia of the nerve and not due to an ischaemic event. (AA abdominal aorta, I Iliac artery, 




Echocardiography was performed to determine the ejection fraction (EF) of left ventricle (LV) 
compared between straight and loop grafts at different time points, but was not found to have 
statistical significance. 
 
Figure 17: Parasternal Long Axis Ejection Fraction Comparison in Straight and Loop 
Grafts Graft showing the ejection fraction in both the loop and straight grafts, with an initial 
decrease in ejection fraction in the first week. Normalization of the ejection fraction back to 
baseline before explant. (p=ns) (EF – Ejection Fraction). 
 
Evaluation of EF of preoperative control group and post-operative EF in Group 1, did not 
reveal any statistical significance. Similar findings were found when comparing aortic 
diameter and peak and mean systolic aortic velocities. None of the results of these 
variables held any statistical significance, but the results did indicate an upward trend in 
specific values of these variables over time and are thus included below.  Weight gain 








Figure 18: Short Axis and Parasternal Long Axis Ejection Fraction Comparison between 




Figure 19: Aortic Peak and Mean Systolic Velocity Comparison between pre-operative 
control group and post-operative straight graft group measurements (p=ns) 













Figure 20: Weight Gain in Straight Graft Group 1 Comparison of weight gain in Group 1 
male versus female rats. (p <0.05) 
 
Weight Gain Straight Graft 
Group 1 





Chronic follow up and long-term review of implanted experimental grafts becomes crucial to 
the success and progress of vascular research.  Evaluation of graft patency by means of 
angiography, considered to be the gold standard, can lead to increased morbidity as this 
requires vascular cannulation and injection of a relatively large volume of contrast, which in 
turn could have detrimental outcomes in small animal models.(7, 11)  After review of multiple 
vascular graft studies, very few research articles elaborate on the means and effectiveness of 
the non-invasive evaluation of patency and occlusion of vascular grafts in small animal 
models.(9, 11, 17-23)  It was therefore proposed that ultrasound could be used as a modality 
in evaluating patency of implanted vascular grafts, and lead to the refinement of our animal 
research.  We applied vascular ultrasound at six different time points post operatively, namely 
at day 1, 3, 7 and week 4, 8 and 12 to detect occlusion. 
 
All the straight grafts were easily detected as patent (Figure 8) at all time points, which was 
confirmed by angiography and histology at 12 weeks.  The sensitivity was high but specificity 
of only 78% was found with a negative predictive value of 85% (Figure 14).  In similar research 
conducted in large animal models, inaccuracy of Doppler findings seemed to be less of a 
problem.  Doppler ultrasonography was found to be more accurate when used to evaluate 
patency or occlusion of implants in carotid arteries in pigs at different time frames, compared 
with angiography.(18)  At four week follow up the NPV was still as high as 95%, PPV of 92%, 
sensitivity of 86% specificity of 92% in determining patency of carotid grafts in pigs.(18) 
 
The difficulties in conducting ultrasound evaluation in small animals versus large animals are 
clearly defined.(3, 24)  In large animals ultrasonographic imaging of tissue is limited to a depth 
of 25cm.(24)  In small animals the depth of imaging is less of a problem but difficulties result 
in separating various tissue planes.  Higher frequency probes are required to improve spatial 
and temporal resolution.(3)  Faster heart rates, the need for anaesthesia and faster reduction 
in body temperatures, which may result in haemodynamic instability during ultrasonography, 
also present additional difficulties in small animals. (10) 
 
The results found in our study (Figure 13), could be explained by the fact that the straight 
grafts could easily be evaluated in the small animal model since the entire length of the straight 
graft could be visualized during ultrasound evaluation (Figure 6).  Visualizing the entire loop 
graft during ultrasound was technically more difficult.  Only the central structure of the graft, 
which consisted of the proximal anastomotic segment, the crossover (central) segment with 
bidirectional flow and the distal anastomotic segment of the loop graft could be assessed in 
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separate frames, due to the size and angles of the graft.  Although the entire looped graft 
could not be visualized in a single frame, we accepted that if we could detect flow, and flow 
related parameters this would be adequate to determine loop graft patency (Figure 7).  
 
This study emphasized the importance of being able to accurately assess patency of 
implanted graft material at any time frame.  Studies have shown the ability of Doppler 
ultrasonography to detect patency in simple graft models, but difficulties do arise in detecting 
occlusion or absence of flow.(7, 25)  It is important to determine the parameters that define 
patency of vascular implants.  Patency may be described using four descriptive modalities, 
namely: [1] Clinical modalities, [2] In vivo non-invasive modality by means of ultrasonography, 
[3] In-vivo invasive modality by means of angiography and [4] Ex-vivo modality by means of 
histological assessment. 
The first modality pertains to the macroscopic clinical evaluation of the graft during 
implantation.  This is not well described in vascular graft literature.(14, 26)  The graft should 
be considered patent if strongly pulsatile and good flow can be observed with distention of the 
distal aorta under vision after completion of infra-renal implantation and needs to be present 
at the time of explant.(14, 26)  Patency may also be assumed if in the acute post-operative 
period, the animal has normal motor function of tail and hind legs.(26)  The latter clinical 
parameter does not hold true in chronic implantation models, since slow occlusion of the 
vessels may lead to collateralization (Figure 10), which would result in adequate perfusion 
leading to an absence of any motor fallout, even in complete occlusion of the graft. 
The second modality is the in-vivo non-invasive functional assessment of patency with 
ultrasonography, which has been described as detecting femoral arterial flow on Doppler 
imaging.(26)  The development of new ultrasound modalities with higher frequency and thus 
resolutions, have made it possible to accurately assess flow in smaller blood vessels.(27)  Use 
of laser Doppler modalities to measure superficial blood flow, is now routinely used, including 
the ability to detect flow in femoral arteries.(26)  But distal superficial flow may arise from 
collaterals.  Studies implementing Laser Doppler measurements, have looked at the flow in 
the hind limbs of rabbits after implantation of multilevel occluded conduits in femoral 
arteries.(28)  Doppler flow indicated surface perfusion, which was contributed by blood flow 
from collateral vessels that formed due to occlusion of the graft. (28) 
As noted in our study, it is not appropriate to assume that pulsatile blood flow through femoral 
arteries translates into patency of aortic vascular grafts.  Our results confirm that even in the 
presence of complete occlusion of the vascular graft, formation of collateral vessels can be so 
extensive that they allow for complete distal femoral arterial flow without any clinical signs of 
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motor function fallout in the animal (Figure 9).  Collateral vessels may also be so large that 
they mimic the same calibre and velocity on Doppler ultrasonography, as aortic flow or flow 
through the patent graft (Figure 10).  This finding is particularly relevant in small rodent models 
such as mice and rats with small calibre grafts. 
Doppler ultrasonography is considered an established method of detecting blood flow.  
However, due to the one dimensional nature of this measurement, there have been concerns 
with regards to its accuracy.(7)  The velocity of blood flow on spectral Doppler is only captured 
in the same direction as the ultrasound beam, with an estimation of the accurate direction of 
the blood flow.(7)  Angle correction is essential to direct the ultrasound beam in an accurate 
direction to flow, so that reliable quantitative velocity measurements will be measured.(2, 7)  
Four parameters need to be met using different modes of ultrasonography to assess the 
functional modality in the evaluation of graft patency.  The graft was recorded as patent under 
a non-invasive modality if the following four criteria were met: [1] The distal lumen of the graft 
could be measured, [2] colour Doppler flow was present in the lumen, [3] measurable distal 
velocity with a triphasic flow pattern and [4] no hyperechoic density could be detected in the 
lumen. 
There were, however, two false positives in the loop graft group, (Figure 9 and Figure 10) 
where the grafts were considered to be patent on Doppler ultrasonography evaluation at 
twelve weeks of implantation with all the above parameters present.  In both cases the grafts 
were found to be occluded on angiography with indeterminate results on histological 
evaluation (Figure 11).  In these two grafts, it was difficult to measure the distal lumen 
diameter, however the distal velocity was obtained with colour and triphasic flow present on 
Doppler.  Both the Ultrasonographers felt that there were significant features suggestive of 
patency of these two grafts.  All the above parameters were absent in the other seven loop 
graft conduits which were correctly detected as occluded on ultrasound evaluation and 
confirmed occluded on angiography at explant (Figure 13).  On review of the ultrasound, with 
the hindsight of angiographic evidence, it was evident that the misinterpretation of flow (colour 
Doppler and triphasic flow) was due to a dense network of large tortuous collateral vessels 
supplying the distal aorta. 
 
The third modality of determining graft patency is angiography, which is invasive and occurs 
at explant.  The fourth modality is a histological assessment of graft patency once explanted 
ex-vivo.  Although the gold standard in determining vascular graft patency is still considered 
to be angiography,(29) histology is often used in vascular graft studies as a surrogate to 
assess graft patency.(14, 30)  In the short straight grafts, the histology correlated well with the 
ultrasound and angiographic findings, however in the longer looped grafts determining 
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occlusion on histology was unreliable (Figure 11).  Looped grafts are more difficult to review 
the entire loop histologically, and preparation of the loop graft into adequate frames is 
technically challenging.  Segmental review of the loop graft results in possible error, since 
certain segments of the graft was found to be patent, where other segments were found to be 
occluded or partially occluded depending on region of the graft assessed.  Ultimately, only 
angiographic results were accepted and compared to ultrasound findings.  
Seven looped grafts in our study were occluded on ultrasonography and confirmed by 
angiography.  Three of these grafts were found to be occluded by 8 weeks, reaching the 
primary endpoint for explant.  An extensive network of collateralization was already confirmed 
on ultrasound as well was angiography with no contrast flow in the loop graft confirming 
occlusion.  The three patent loop grafts were explanted earlier than the 12 week study 
endpoint, due to humane endpoints being reached, (Figure 12). Two of these animals had 
excessive weight loss, and the third animal had earlier termination of implantation due to 
necrosis of the tail tip.  In all three animals ultrasonography detected patency of the loop graft 
and this was confirmed on angiography prior to euthanasia of the animals.  A filling defect 
could be appreciated on Doppler ultrasonography of the caudal artery, from what was 
suspected to be an embolism to the tail (Figure 12).  Doppler ultrasonography showed no 
occlusion of the graft itself, and patency was confirmed on angiography at explant with a filling 
defect of the caudal artery. 
The loop graft implants were technically more difficult in female rats.  Female rats had a lower 
weight gain compared to male rats after implantation, this was statistically significant in Group 
1, the straight grafts (Figure 20).  Due to difficulties of implanting loop vascular grafts in female 
rats weighing less than 300 grams, as a result of smaller aortic size and smaller abdominal 
cavity to accommodate the large loop graft, fewer females were used in Group 2 and could 
thus not indicate a statistical significance with regards to weight gain.  We would not advocate 
the use of female rats in straight and loop graft implantation studies in the future.   
As an operator dependent investigation, there is a learning curve involved in conducting 
ultrasonography.  All our images were confirmed by a skilled small animal Ultrasonographer 
and yet there was still room for error. There is a need to familiarize oneself with the various 
images and views when dealing with complex vascular graft models, which will help to readily 
detect complications in these grafts.  Due to the construction of the loop graft it was impossible 
to visualize flow in all regions of the graft.  One could only assess the regions of proximal and 
distal anastomoses and detect flow in the area of “cross-over” in the centre of the loop graft 
(Figure 7).  We could assess the diameter, velocity and colour flow at the proximal and distal 
anastomoses of the loop graft with spectral Doppler ultrasonography.  In patent grafts we 
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could detect all the above, including good laminar triphasic flow. The above parameters were 
obscured in the two false positive cases described where large tortuous collateral vessels 
were supplying distal flow.  This is one of the known limitations of ultrasonography.  The loop 
graft is a complex tortuous model and we are the only group at present doing loop graft 
models, which presented with the known ultrasonographic limitations.  The use of 
ultrasonography was very effective in the straight grafts. 
As an additional finding, it was noted that the ejection fraction initially decreased post 
operatively in both the straight and loop grafts but the ejection fraction normalized back to 
baseline weeks after implantation (Figure 17).  It was speculated that the loop graft may add 
additional afterload to the left ventricle of the heart, leading to a compromise in ventricular 
function, although this was not statistically significant, the trend suggests that the longer graft 
may result in depressed cardiac function.  This finding is however confounded by the 
significant difference in the patency in the two groups. During ultrasonography and 
echocardiography we also assessed the aortic peak and mean velocities and ejection fraction 
between the pre-operative control group and Group 1 (straight grafts) (Error! Reference 
source not found. and Error! Reference source not found.), but no statistical significant 
changes were present in any variable in comparison to each group as depicted in the grafts 
displayed. 
There were additional limitations to the study which included the intervals of ultrasonography 
post-operatively.  The initial ultrasound imaging was found to be complicated by abdominal air 
in the early post-operative period.  This made imaging difficult and sometimes did not 
contribute significantly or allow for adequate imaging of the graft.  We also noted that the initial 
post-operative echocardiogram showed a very empty “kissing” left ventricle (Figure 15), which 
led to the adjustment of management with an additional fluid resuscitation given to the animals 
in the immediate post-operative period to improve ventricular filling.  Concern was raised with 
regards to stability of the animals during ultrasonography due to these findings, and therefore 
a decision was made not to perform imaging in the immediate post-operative period. 
Echocardiography may however be used to determine animal volume status if required. 
Clearer images were obtained from day 3 post-operatively when animals started eating and 
ileus subsided with adequate fluid resuscitation and better haemodynamic stability.  Imaging 
done within 48 hours of the abdominal implantation rendered poorer images than those 
conducted later.  We would also suggest doing weekly ultrasound evaluation of grafts instead 
of monthly since smaller changes attributing to occlusion of grafts could be more adequately 
followed on a weekly basis.  
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Even with the above limitations, ultrasonography allowed us to perform long-term follow up of 
our grafts, hence evaluation of grafts were not only limited to the day of explant.  Another 
important use of ultrasound is the ability to review various flow parameters and soft tissue 
structures in the regions surrounding the surgical field.  The one animal excluded from the 
study was euthanised after detecting a large distended bladder on ultrasonographic 
evaluation.  The animal had cystitis and due to concerns of graft contamination and poor 
condition of the animal, the decision was made to euthanise the rat, and exclude the data from 
the study.  Ultrasound therefore does not only allow for chronic follow up of vascular graft 
status itself, but could allow for chronic follow up that would have led to later or earlier 
termination of animals in the study.   
Ultrasonography thus also improves the quality of research conducted.  This is additionally 
noted during the implantation of our vascular grafts, when clamping the iliolumbar vein to inject 
heparin.  This procedure has a risk of a neuropraxia of the iliolumbar nerve.  This occurred in 
two animals presenting with a unilateral leg lag.  Routinely these animals would have been 
euthanised due to concerns that the neurological fallout is due to an ischaemic event of the 
leg as a result of a vascular graft complication. We could, however, confirm flow in the graft 
and distal iliac arterial flow (Figure 16), excluding any acute ischaemic event and the animals 
were not euthanised.  The Neuropraxia resolved completely within seven days post-
operatively.  Ultrasonography additionally allows for the review and chronic evaluation of graft 
flow characteristics, presence of aneurysm formation and extent of aortic dilatation, assessing 
parameters like vessel pulsatile flow, distensibility and stiffness.(11, 31)  All information was 
obtained by means of chronic follow-up with ultrasonography over time.  
Our study had a specificity of 100% but limitation in sensitivity to detect occlusion of 78% with 
PPV of 100% but NPV of 85% (Figure 14).  This does leave some doubt with regards to 
detecting occlusion of the graft in more complex loop models, but it could limit angiographic 
evaluation to difficult cases where doubt of patency on ultrasonography is present.  
Ultrasonography allows for follow-up examinations to be performed with minimal 
consequences and discomfort to the animals or researchers.  It should be seen as a modality 




It is essential that during vascular graft implantation, patency may be regularly evaluated and 
accurately determined.  Ultrasound is easily accessible providing repeatable, rapid and safe 
results at any time point post operatively.  In our setting, the greater complexity of vascular 
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grafts makes imaging more difficult but considering the benefits of ultrasonography it may be 
worth investing in additional non-invasive imaging modalities.  The complexity of imaging can 
be simplified with combination of more advanced non-invasive imaging modalities that 
complement each other and may be used to confirm findings.  Newer prospective studies are 
required to establish optimum techniques of vascular graft imaging. We have found that this 
is a feasible and advantageous diagnostic technique supplying additional knowledge, at very 
little risk to animals that we could implement in our current vascular graft models in rodents. 
6. Limitations 
 
Study is limited by small numbers in the experimental groups. Another limitation includes the 
uneven division of the groups between male and female Wistar rats, due to difficulties of 
implantation of the loop graft model in smaller animals like the female rats, weighing less at 
implantation. Additional limitations to be addressed in future studies is the absence of an 
occlusion model in the straight graft implants. Ultrasonographic interpretation of a ligated 
straight graft and haemodynamic effects could yield additional findings in future studies. 
Consideration in future studies would be to examine flow dynamics in earlier time points in 
grafts at risk of occlusion, since the onset of occlusion occurred earlier than the time points 
reported in this study. 
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Section 3: Future Directions 
 
Improvements of MRI and CT imaging can provide additional information but these are 
expensive modalities and not readily available in our small animal research units as yet. 
There are multiple non-invasive modalities available including contrast induced 
ultrasonography and as soon as cost and funding allow, should be implemented in all small 
animal research units. 
 
Information obtained in this study of the implementation of ultrasographic imaging of our 
units vascular grafts models, will now be incorporated in future studies.  We are 
implementing the technique of electrospinning in fabricating biodegradable polymer 
vascular grafts in a PHD study.  The skills and training obtained in this MMED thesis, with 
regards to graft implantation and ultrasonographic imaging, will now be implemented in 
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